About Depression
Understanding the Scope, Science, and Brain Circuitry of Major Depressive Disorder
16 Million+
U.S. Adults Affected Annually (6.7%)1
$210 Billion
U.S. Annual Economic Burden2
4 Million+
Patients Unhelped by Medications
Depression is a serious medical illness affecting more than 16 million American adults every year—6.7% of all U.S. adults1. Often a debilitating disorder, depression results in a persistent state of sadness or loss of interest or pleasure which interferes with an individual’s thoughts, behavior, mood, and physical health. Learn more about depression symptoms.
In 2010, the economic burden of depression was estimated at $210 billion in the US2, and depression was the second leading cause of disability, accounting for almost 20% of all years of life lost to disability and premature death3.
Depression can be a lethal disease. In fact, each year in the US, over 44,000 people die by suicide, 60% of whom suffer from depression4,5. Overall, women are almost twice as likely as men to suffer from depression; however, some experts feel that depression in men is under-reported6. Depression has no racial, ethnic, or socioeconomic boundaries. About two-thirds of those who experience an episode of depression will have at least one other episode in their lives.
The Neuroscience & Brain Circuitry of Depression
While the exact cause of depression is not known, the leading scientific theory is that depression is caused by decreased activity in the neural networks of the brain that regulate emotion and motivation. Increasing levels of neurotransmitters in the brain has been found to reactivate these neural networks, or create new networks.
Neurotransmitters are chemical messengers that send signals between brain cells. Depression is most often treated with antidepressant medications. It is believed that antidepressant medications work by increasing the levels of these neurotransmitters.
However, more than 4 million patients do not receive adequate benefit from antidepressants and/or cannot tolerate the side effects caused by them. For these patients, they need a new way back.
References:
- Center for Behavioral Health Statistics and Quality. (2016). 2015 National Survey on Drug Use and Health: Detailed Tables. Substance Abuse and Mental Health Services Administration, Rockville, MD.
- Greenberg PE, et al. The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010). J Clin Psychiatry. 2015; 76(2):155-162.
- US Burden of Disease Collaborators. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA, 310(6): 591-608, 2013.
- Arias E, Heron M, Xu JQ. United States life tables, 2012. National vital statistics reports; vol 65 no 8. Hyattsville, MD: National Center for Health Statistics. 2016.
- Courtet, P. and Lopez-Castroman, J. (2017), Antidepressants and suicide risk in depression. World Psychiatry, 16: 317-318. doi:10.1002/wps.20460
- Martin LA, Neighbors HW, Griffith DM. The Experience of Symptoms of Depression in Men vs Women Analysis of the National Comorbidity Survey Replication. JAMA Psychiatry. 2013;70(10):1100-1106. doi:10.1001/jamapsychiatry.2013.1985
Explore Related Resources
What is TMS Therapy?
Understand how TMS works
Is TMS Right for Me?
Candidacy and screening
Typical TMS Treatment
What a course looks like
TMS Clinical Study Results
Research findings
About Depression
Understanding the condition
Depression Symptoms
Recognizing the signs
Treating Depression
Treatment approaches
Videos & Media
Watch patient stories
Financing Options
Payment and financing
Supplemental Research
Additional studies and data
Virtual Education
Online learning resources
SAINT® Accelerated TMS
FDA-cleared, 5-day accelerated TMS protocol
Standard TMS Therapy
Non-invasive magnetic stimulation for depression
SPRAVATO® (Esketamine)
FDA-approved nasal spray for TRD
Prism for PTSD
EEG neurofeedback for PTSD symptoms
Proliv®Rx At-Home TMS
At-home neuromodulation device
Ampa One System
Single-day accelerated TMS protocol
IV Ketamine Infusions
Rapid-acting IV ketamine therapy
Ketamine-Assisted Psychotherapy
KAP combines ketamine with therapy
PrTMS Therapy
Personalized repetitive TMS
Psychotherapy & Counseling
CBT, DBT, EMDR, and more
Medication Management
Psychiatric medication oversight
Ampa One Day Accelerated Protocol
Single-day accelerated protocol
TMS for Depression
FDA-cleared TMS for treatment-resistant depression
TMS for Anxiety
Non-drug neuromodulation for anxiety
TMS for PTSD
Targeted stimulation for trauma circuits
TMS for OCD
SmartFocus® 3D targeting for OCD
Let's find your path forward — together
Reaching out is the hardest part, and you've already started. Tell us a little about yourself and our compassionate care team will reach out within one business day to answer your questions, verify your insurance, and help you take the next step — at no cost and no obligation.
Two pathways to care: self-pay offers the fastest access (most patients start within days, with appointments available seven days a week), or we accept Blue Cross Blue Shield in select states and the BCBS Federal Employee Program in select states. We'll help you find the right path for your situation.
- Warm, judgment-free consultation — no pressure, just answers
- Flexible scheduling: Zoom or in-person, including weekends
- Same-day or next-day appointments often available